HOUSTON — The crew selected for NASA's Artemis 2 mission has officially embraced the excitement surrounding their lunar journey. **Artemis 2 Crew Gets an Inspiring Glimpse of the Moon Ahead of Historic Flyby** As the Artemis 2 mission continued its celestial journey,...
Science news this week: Artemis II lifts off, diabetes cured in mice, and smog in China shapes Arctic storms
NASA's highly anticipated Artemis II mission seized the global scientific spotlight this week, culminating in a historic launch on Wednesday, April 1. From Cape Canaveral, Florida, the space agency successfully sent its first crewed mission toward the moon in over...
NASA telescope uncovers new mystery in supernova first spotted by Chinese astronomers 2,000 years ago — Space photo of the week
A cutting-edge NASA space telescope has offered a fresh perspective on one of the oldest recorded astronomical events observed by humankind. Dating back to A.D. 185, ancient Chinese astronomers meticulously documented a mysterious celestial phenomenon they referred to...
‘This generation’s moment’: How the Artemis missions will reframe humanity’s relationship with the moon
For millennia, the Moon has held a multifaceted significance far beyond its visual presence in the night sky. It has served as a primal clock dictating tides and seasons, a guiding beacon for explorers, a revered deity inspiring myths, and a captivating enigma driving...
Are allergies genetic?
**Allergies are a growing concern in the United States, affecting over 100 million individuals and more than 30% of the adult population. This widespread health issue raises important questions about its origins: are allergies a matter of genetic inheritance, or are...
Cheap, decades-old transplant drug delays full onset of type 1 diabetes
Here are a few options, maintaining a clear, journalistic tone: **Option 1 (Direct and Punchy):** > New research indicates that a decades-old, inexpensive medication, commonly employed in transplant operations, could significantly slow the advance of type 1 diabetes...
Diabetes rates are lower in high-altitude environments — and scientists may have discovered why
The long-puzzling phenomenon of lower diabetes rates in high-altitude regions may finally have an answer. A groundbreaking new study in mice unveils a compelling potential explanation: red blood cells, central to oxygen delivery throughout the body, appear to actively...
Evaluating the ethics of autonomous systems
Artificial intelligence is rapidly establishing itself as a pivotal tool for enhancing strategic decision-making in vital, high-consequence scenarios. A compelling illustration comes from the energy sector, where self-governing AI systems can precisely identify power...
Working to advance the nuclear renaissance
The United States leads the world in nuclear power, operating 94 reactors that collectively generate nearly 20 percent of the nation’s electricity. While acknowledging this as a significant achievement, nuclear engineer Dean Price emphasizes that the country needs to...
NASA’s Artemis 2 astronauts are cruising to the moon. So why are they doing CPR tests today?
Here are several options for paraphrasing the text, maintaining a unique, engaging, and journalistic tone: **Option 1 (Focus on effortless nature):** > HOUSTON — Embarking from the city, this journey is poised to redefine effortless travel, almost navigating itself....
April full moon 2026 dazzles as ‘Pink Moon’ lights up skies worldwide (photos)
On April 1st, a spectacular full moon, known to observers as the "Pink Moon," graced the night sky. This celestial event occurred just hours before NASA's Artemis 2 mission commenced, embarking on a ten-day voyage with four astronauts destined for the far side of the...
Astronauts on the ISS watched NASA’s historic Artemis 2 launch from space
Here are a few options for paraphrasing the text, maintaining a clear, journalistic tone: **Option 1 (Focus on observation beyond Earth):** > The historic launch of NASA's Artemis II mission to the moon from Florida's Space Coast earlier this week captivated audiences...












